ATE372787T1 - Atelocollagen enthaltende gen-zusammensetzungen - Google Patents

Atelocollagen enthaltende gen-zusammensetzungen

Info

Publication number
ATE372787T1
ATE372787T1 AT96921138T AT96921138T ATE372787T1 AT E372787 T1 ATE372787 T1 AT E372787T1 AT 96921138 T AT96921138 T AT 96921138T AT 96921138 T AT96921138 T AT 96921138T AT E372787 T1 ATE372787 T1 AT E372787T1
Authority
AT
Austria
Prior art keywords
compositions containing
gene compositions
containing atelocollagen
gene
atelocollagen
Prior art date
Application number
AT96921138T
Other languages
English (en)
Inventor
Masaaki Terada
Takahiro Ochiya
Teruo Miyata
Hiroshi Itoh
Original Assignee
Koken Kk
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Kk, Dainippon Sumitomo Pharma Co filed Critical Koken Kk
Application granted granted Critical
Publication of ATE372787T1 publication Critical patent/ATE372787T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96921138T 1995-07-03 1996-07-02 Atelocollagen enthaltende gen-zusammensetzungen ATE372787T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16774495 1995-07-03

Publications (1)

Publication Number Publication Date
ATE372787T1 true ATE372787T1 (de) 2007-09-15

Family

ID=15855313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921138T ATE372787T1 (de) 1995-07-03 1996-07-02 Atelocollagen enthaltende gen-zusammensetzungen

Country Status (12)

Country Link
EP (1) EP0844004B1 (de)
KR (1) KR100431779B1 (de)
CN (1) CN1230205C (de)
AT (1) ATE372787T1 (de)
AU (1) AU704694B2 (de)
CA (1) CA2225998C (de)
DE (1) DE69637243T2 (de)
ES (1) ES2293648T3 (de)
IL (2) IL122802A0 (de)
NZ (1) NZ311175A (de)
TW (1) TW577747B (de)
WO (1) WO1997002047A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543994B1 (ko) * 1996-04-12 2006-10-31 더 리젠츠 오브 더 유니버시티 오브 미시건 상처치료를위한invivo유전자전달방법
US7052875B1 (en) 1998-05-22 2006-05-30 Sumitomo Pharmaceutical Company, Limited Stable gene preparations
ES2277438T3 (es) 1998-07-01 2007-07-01 Takara Bio Inc. Metodos de transferencia de genes.
AU2001264317A1 (en) * 2000-06-20 2002-01-02 Koken Co., Ltd. Preparations for oligonucleotide transfer
EP3251722B1 (de) * 2001-04-20 2020-06-17 ALZA Corporation Mikroprojektionsanordnung mit einer beschichtung, der ein vorteilhaftes mittel enthält und beschichtungsverfahren dafuer
ATE444773T1 (de) * 2001-04-20 2009-10-15 Alza Corp Mikroprojektionsanordnung mit einem überzug, der ein vorteilhaftes mittel enthält
EP1407787B1 (de) * 2001-06-20 2009-04-29 Dainippon Sumitomo Pharma Co., Ltd. Verfahren zur förderung des nukleinsäuretransfers
EP1480656A4 (de) * 2002-02-15 2007-07-18 Res Dev Foundation Hyaluronsäure-vermittelte adenovirus-transduktion
WO2005077333A2 (en) * 2004-02-10 2005-08-25 University Of Florida Research Foundation, Inc. Gel-based delivery of recombinant adeno-associated virus vectors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126217A (ja) * 1983-12-14 1985-07-05 Sumitomo Chem Co Ltd 長期徐放性製剤
JPH0657658B2 (ja) * 1985-04-11 1994-08-03 住友製薬株式会社 徐放性製剤
JPH0759522B2 (ja) * 1985-12-27 1995-06-28 住友製薬株式会社 徐放性製剤の製造法
DE3802158A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Vorrichtung zur applikation von implantaten
JP3187410B2 (ja) * 1989-08-10 2001-07-11 住友製薬株式会社 脳内投与用徐放性製剤
JP2789115B2 (ja) * 1989-09-07 1998-08-20 株式会社高研 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法
CA2109955A1 (en) * 1991-05-24 1992-11-26 Toru Hayakawa Equipment for intracerebral administration of preparations
AU6637394A (en) * 1993-04-19 1994-11-08 Medisorb Technologies International L.P. Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
EP0804249A2 (de) * 1994-03-15 1997-11-05 Brown University Research Foundation Polymeres system zur freisetzung von genen

Also Published As

Publication number Publication date
TW577747B (en) 2004-03-01
IL122802A0 (en) 1998-08-16
EP0844004B1 (de) 2007-09-12
AU704694B2 (en) 1999-04-29
WO1997002047A1 (fr) 1997-01-23
KR19990028522A (ko) 1999-04-15
CA2225998A1 (en) 1997-01-23
AU6243696A (en) 1997-02-05
EP0844004A1 (de) 1998-05-27
CN1230205C (zh) 2005-12-07
IL122802A (en) 2007-09-20
ES2293648T3 (es) 2008-03-16
CN1193916A (zh) 1998-09-23
CA2225998C (en) 2010-11-02
NZ311175A (en) 1999-11-29
EP0844004A4 (de) 2000-03-15
DE69637243D1 (de) 2007-10-25
DE69637243T2 (de) 2008-06-19
KR100431779B1 (ko) 2004-09-04

Similar Documents

Publication Publication Date Title
ITRM940324A0 (it) "formulazioni galenione contenenti macrolidi".
KR100253672B1 (en) Methods and applications for efficient genetic suppressor elements
AU5153296A (en) Vectors for gene delivery
FR2696039B1 (fr) Structure de support d'aimant.
MX9800625A (es) Marcfortinas y paraherquamidas antiparasitarias.
BR9808491A (pt) Compostos calcilìticos
NO952366D0 (no) Dolostatin-analog
DK1584682T3 (da) Regulering af bcl-2 gene ekspression
EP0773296A4 (de) Gen für ein sekretionssignal und dieses enthaltender vektor
ATE372787T1 (de) Atelocollagen enthaltende gen-zusammensetzungen
ATE440960T1 (de) T-helferzellen-epitope
DE69602140D1 (de) Elektronenmikroskopprobenträger
EP0620638A3 (de) Verstärkeranordnungen für einen integrierten Schaltkreis.
FR2755699B1 (fr) Nouvelles constructions et vecteurs pour l'expression ciblee et inductible des genes
FI962240A0 (fi) Kasviperäiset arabinogalaktaani (AGP) geenit
ITTO940028A0 (it) Gruppo di cuscino d'aria perfezionato per autoveicoli.
FR2714074B1 (fr) Promoteurs des gènes GRA1, GRA2, GRA5 et GRA6 de toxoplasma gondii et vecteurs d'expression comprenant lesdits promoteurs.
AU1771799A (en) Acetyl-coa-carboxylase from candida albicans
FR2702179B1 (fr) Support adaptable pour liste d'achats.
DE69829236D1 (de) Zusammensetzungen enthaltendes biologisch aktives Silizium
DE69627417D1 (de) Fluoreszierende-Weissmacher-enthaltende Zubereitungen
ZA964359B (en) "Novel Antiproliferative Protein from Bacillus Thuringiensis Var. Thuringiensis".
FR2691353B1 (fr) Implant porteur d'une lentille intra-oculaire.
AU3019592A (en) A novel translational activating sequence
HK1030630A (en) Novel vectors and genes exhibiting increased expression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties